Commitment COM-388
Post-approval commitment for MHRA-2022-0088. Category: Paediatric Study. Priority: high.
Commitment ID
COM-388
Application
Authority
Medicines and Healthcare products Regulatory Agency
Category
Paediatric Study
Priority
high
Status
Overdue
Due Date
2025-01-26
Completed At
—
Owner
Nadia Petrova
Created
2022-09-22
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.